CSM Advisors’s Amphenol APH Stock Holding History

CSM Advisors’s Portfolio APH Stock Details APH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.27M	Buy	41,249 +3,520	+9%	+$507K	0.16%	159
2026 Q1	$4.77M	Buy	+37,729	New	+$5.31M	0.12%	201

Other funds holding APH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CSM Advisors's APH Position: Q2 2026 in Review

CSM Advisors increased its Amphenol (APH) stake by 9.3% in Q2 2026, buying an estimated $507K and bringing the position to 41,249 shares worth $7.27M. The position accounts for 0.16% of the portfolio, ranked #159.

CSM Advisors first reported a position in APH in Q1 2026 and has held it in 2 quarters since. 2,315 funds tracked by Wall St. Rank hold APH as of Q2 2026.

CSM Advisors held 41,249 shares of Amphenol worth $7.27M as of Q2 2026.
CSM Advisors bought 3,520 Amphenol shares in Q2 2026, an estimated $507K.
Amphenol made up 0.16% of CSM Advisors's portfolio in Q2 2026, its #159 holding.
CSM Advisors first reported a position in Amphenol in Q1 2026 and has held it in 2 quarters since.
2,315 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.